✦ LIBER ✦

In vitro and in vivo effects of BT563, an anti-interleukin-2 receptor monoclonal antibody

✍ Scribed by T. VanGelder; C. R. Daane; L. M. B. Vaessen; C. J. Hesse; W. Weimar; B. Mochtar; A. H. M. M. Balk

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunological effects of the anti-IL-2 r

✍ B Nashan; R Schwinzer; HJ Schlitt; K Wonigeit; R Pichlmayr 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 767 KB

Pharmacodynamics of prophylactic antirej

✍ Cees J. Hesse; Teun van Gelder; Lennard M.B. Vaessen; Christiaan J. Knoop; Aggie 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 746 KB

In vitro and in vivo effects of an anti-

✍ S Ko; H Nakano; A Deiwick; A Dinkel; K Wonigeit; H.J Schlitt 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Treatment of multiple sclerosis with an

✍ John W. Rose; Hilary E. Watt; Andrea T. White; Noel G. Carlson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Anti-interleukin 2 receptor monoclonal a

✍ Daniel Olive; Jérǒme Raymond; Patrice Dubreuil; Dominique Charmot; Yannick Jacqu 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

Effect of anti-class II and interleukin-

✍ A. Górski; T. Glapiński; G. Korczak-Kowalska; M. Nowaczyk 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 87 KB